Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Characterization and treatment of resistant hypertension Pisoni R; Ahmed MI; Calhoun DACurr Cardiol Rep 2009[Nov]; 11 (6): 407-13Resistant hypertension is a common medical problem. It carries a significantly increased risk of end-organ damage and cardiovascular events compared with more easily controlled hypertension. Resistant hypertension is most often related to isolated systolic hypertension and is characterized by aldosterone excess and increased intravascular volume. Its diagnosis requires the exclusion of pseudoresistance. The etiology of resistant hypertension is almost always multifactorial. Common reversible contributing factors need to be identified and addressed. Secondary causes of hypertension, such as primary aldosteronism, parenchymal and vascular kidney disease, and obstructive sleep apnea, require investigation and effective treatment if present. Therapy for resistant hypertension should be based on use of rational drug class combinations at optimal doses, with particular attention to adequate diuretic use. The addition of an aldosterone antagonist may further improve blood pressure control.|Adrenal Gland Neoplasms/complications[MESH]|Antihypertensive Agents/*therapeutic use[MESH]|Blood Pressure[MESH]|Drug Resistance[MESH]|Humans[MESH]|Hyperaldosteronism/complications[MESH]|Hypertension/*drug therapy/epidemiology/etiology[MESH]|Kidney Failure, Chronic/complications[MESH]|Life Style[MESH]|Obesity/complications[MESH]|Pheochromocytoma/complications[MESH]|Pituitary ACTH Hypersecretion/complications[MESH]|Prevalence[MESH]|Prognosis[MESH]|Renal Artery Obstruction/complications[MESH]|Risk Factors[MESH]|Sleep Apnea, Obstructive/complications[MESH]|Treatment Failure[MESH]|United States/epidemiology[MESH] |